PFIZER19.BK Pfizer Inc.

- THB
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
5.82%
Fundamental score
-

Is PFIZER19.BK undervalued?

Graham number

The Graham number of Pfizer Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pfizer Inc. fundamental analysis

No fundamental analysis for Pfizer Inc. yet.

Pfizer Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, …

Full company profile